Thalidomide

Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

Safety and Efficacy of Hemoglobin F Inducers in Patients With Beta Thalassemia

Metronomic Gemcitabine, Mitomycin C, and Thalidomide for Advanced Solid Tumors

Efficacy of Combination of Hdroxyurea and Thalidomide Over Hydroxyurea or Thalidomide in the Treatment of Transfusion Dependent Thalassemia in Children

Efficacy and Safety Study of Dovramilast in People With Leprosy Type 2 Reaction

UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission

Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma

Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy

A Clinical Study to Test the Effects of Ruxolitinib And Thalidomide Combination for Patients With Myelofibrosis

Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury.

Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors

The Efficacy of TCD Following by TP Maintenance Therapy in Newly Diagnosed WM

EDOCH Alternating With DHAP for New Diagnosed Younger MCL

UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy

Thalidomide in Treating Patients With Relapsed or Progressive Systemic Mastocytosis

2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy

Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Aponermin-Based Bridging Therapy Prior to CAR-T Infusion in Relapsed/Refractory Multiple Myeloma Patients With Extramedullary Disease

Unraveling the Impact of Thalidomide at Diverse Doses in Transfusion Dependent Beta Thalassemia

Long Term Beta Thalassemia Treatment: Findings From The Extension Period